Contribution: Regional Economic Growth through Innovation
Path Therapeutics, Inc.
$40,000.00
000017118
FY 2020-21 · 2020-07-07
Summary
To support business needs while recovering from COVID-19
Department
Program
Regional Economic Growth through Innovation
Recipient
Location
Calgary, Alberta, Canada
Recipient Type
For-profit organization
Business Number
800686230
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2021-04-30
Agreement Number
000017118
Agreement Start Date
2020-07-07
Agreement Title
000017118
Agreement Title (French)
000017118
Agreement Type
Contribution
Agreement Value
$40,000.00
Amendment Number
0
Description
To support business needs while recovering from COVID-19
Description (French)
Soutenir les besoins opérationnels alors qu'on se remet de la COVID-19
Expected Results
Western Canadian communities have necessary public infrastructure and adjustment support to promote economic growth.
Expected Results (French)
Les collectivités de l'Ouest canadien disposent de l'infrastructure publique et du soutien à l'adaptation nécessaires pour promouvoir la croissance économique.
Federal Riding
Calgary Confederation
Federal Riding (French)
Calgary Confederation
Federal Riding Number
05
NAICS Code
000000
Organization Code
wd-deo
Organization
Western Economic Diversification Canada | Diversification de l'économie de l'Ouest Canada
Program Name
Regional Economic Growth through Innovation
Program Name (French)
Croissance économique régionale par l'innovation
Program Purpose
Provide streamlined, nationally consistent and yet regionally tailored support for business productivity and scale-up, particularly for small and medium-sized enterprises (SMEs) and women entrepreneurs and other underrepresented groups, and assist the enhancement of regional industrial and technology clusters and regional innovation ecosystems.
Program Purpose (French)
Fournir un soutien simplifié uniforme à l'échelle nationale mais adapté à l'échelle régionale pour la productivité et la croissance des entreprises, particulièrement au profit des petites et moyennes entreprises (PME) et des femmes entrepreneurs et autres groupes sous-représentés, et contribuer à l'amélioration des grappes industrielles et technologiques régionales et des écosystèmes d'innovation régionaux.
Recipient Business Number
800686230
Recipient City
Calgary
Recipient Country
CA
Recipient Legal Name
Path Therapeutics, Inc.
Recipient Operating Name
Path Therapeutics, Inc.
Recipient Postal Code
T2N 3T3
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
GC-WD-DEO-2020-2021-Q2-960
